Regal Assets Analytics

SOBI

Selecta Licenses Away Promising Gout Drug; SanaCurrents Suspending Coverage

By |2020-10-20T14:49:51-04:00June 12th, 2020|Categories: Bill Langbein, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents Updates|Tags: , |

After the market closed on June 11, Selecta Biosciences, Inc. [...]

Swedish Orphan Biovitrum AB Probability Sentiment

By |2020-10-20T14:50:58-04:00January 31st, 2020|Categories: Bill Langbein, Healthcare, Insights, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Probability Sentiment|Tags: , |

Swedish Orphan Biovitrum AB (OTCPINK:BIOVF) (STO:SOBI) Probability Sentiment [...]